Aging and outcome in schizophrenia

Acta Psychiatrica Scandinavica

Volumn 107, Issue 5, 2003, Pages 336-343

  Jeste, Dilip V ^a   Twamley, E W ^b   Eyler Zorrilla, L T ^b   Golshan, S ^b   Patterson, T L ^b   Palmer, B W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Aged; Middle age; Out patients; Psychotic disorders

Indexed keywords

BENZATROPINE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

ADULT; AGE; AGED; AGING; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; DETERIORATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOTOR DYSFUNCTION; OUTCOMES RESEARCH; OUTPATIENT; PHYSICAL CAPACITY; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SCHIZOPHRENIA; SYMPTOM; WELLBEING;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; CALIFORNIA; COGNITION DISORDERS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 0038136815     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0447.2003.01434.x     Document Type: Article

References (44)

1. FEIGHNER JP, ROBINS E, GUZE SB, WOODRUFF RA, WINOKUR G, MUNOZ R. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972;26:57-63.
2. SPITZER RL, ENDICOTT J, ROBINS E. Research diagnostic criteria (RDC) for a selected group of functional disorders, 2nd edn. New York: New York State Psychiatric Institute, 1975.
3. HARVEY PD, LEFF J, TRIEMAN N, ANDERSON J, DAVIDSON M. Cognitive impairment in geriatric chronic schizophrenic patients. A cross-national study in New York and London. Int J Geriatr Psychiatry 1997;12:1001-1007.
4. HEATON RK, GLADSJO JA, PALMER BW, KUCK J, MARCOTTE TD, JESTE DV. Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry 2001;58:24-32.
5. MASON P, HARRISON G, GLAZEBROOK C et al. Characteristics of outcome in schizophrenia at 13 years. Br J Psychiatry 1995;167:596-603.
6. BLEULER M. A 23-year longitudinal study of 208 schizophrenics and impressions in regard to the nature of schizophrenia. In: ROSENTHAL D, KETY SS, eds. The transmission of schizophrenia. New York: Pergamon Press, 1968:3-12.
7. HUBER G, GROSS G, SCHUTTLER R, LINZ M. Longitudinal studies of schizophrenia patients. Schizophr Bull 1980;6: 592-605.
8. CIOMPI L. Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophr Bull 1980;6: 606-618.
9. HARDING C, BROOKS G, ASHIKAGA T, STRAUSS J, BREIER A. The Vermont longitudinal study of persons with severe mental illness II. Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry 1987;144:727-735.
10. HARRISON G, HOPPER K, CRAIG T et al. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry 2001;178:506-517.
11. EYLER ZORRILLA LT, HEATON RK, MCADAMS LA, ZISOOK S, HARRIS JM, JESTE DV. Cross-sectional study of older outpatients with schizophrenia and healthy comparison subjects: no differences in age-related cognitive decline. Am J Psychiatry 2000;157:1324-1326.
12. PALMER BW, HEATON SC, JESTE DV. Older patients with schizophrenia: challenges in the coming decades. Psychiatr Serv 1999;50:1178-1183.
13. COHEN CI, COHEN GD, BLANK K et al. Schizophrenia and older adults: an overview: directions for research and policy. Am J Geriatr Psychiatry 2000;8:19-28.
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. Washington, DC: American Psychiatric Press, 1987.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
16. FIRST MB, SPITZER RL, GIBBON M, WILLIAMS JBW. Structured clinical interview for DSM-IV Axis 1 Disorder-Patient Edition (SCID-I/P). New York: Biometrics Research Department, New York State Psychiatric Institute, 1995.
17. SPITZER RL, WILLIAMS JB, GIBBON M, FIRST MB. Structured clinical interview for the DSM-III-R. Washington, DC: American Psychiatric Association, 1990.
18. JESTE DV, CALIGIURI MP, PAULSEN JS et al. Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 patients. Arch Gen Psychiatry 1995;52: 756-765.
19. Overall JE, Gorham DR. The brief psychiatric rating scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull 1988;24:97-99.
20. ANDREASEN NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: The University of Iowa, 1984.
21. HAMILTON M. Development of a rating scale for primary depressive illness. Br J Social Clin Psychology 1967;6: 278-296.
22. SIMPSON GM, ANGUS JW, A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970;46(Suppl 212): 11-19.
23. National Institute of Mental Health. Abnormal Involuntary Movement Scale (AIMS). In: GuY W, ed. ECDEU Assessment manual for psychopharmacology - revised. Rockville, MD: US Department of Health, Education, and Welfare, 1976:534-537.
24. KAPLAN RM, ANDERSON JP. The Quality of Well-Being scale: rationale for a single quality of life index. In: ROSSER R, WALKER SR, eds. Quality of life: assessment and application. London: MTP Press, 1988;51-77.
25. PFEFFER RI, KUROSAKI TT, HARRAH CH, CHANCE JM, FILOS S. Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323-329.
26. HEATON R, PAULSEN J, MCADAMS LA et al. Neuropsychological deficits in schizophrenia: relationship to age, chronicity and dementia. Arch Gen Psychiatry 1994; 51:469-476.
27. HOWARD R, RABINS PV, SEEMAN MV, JESTE DV and the International Late-Onset Schizophrenia Group. Late-onset schizophrenia and very-late-onset schizophrenia-like psychois: an international consensus. Am J Psychiatry 2000;157:172-178.
28. JESTE DV, SYMONDS LL, HARRIS MJ, PAULSEN JS, PALMER BW, HEATON RK. Non-dementia non-praecox dementia praecox? Late-onset schizophrenia. Am J Geriatr Psychiatry 1997;5:302-317.
29. JESTE DV, ALEXOPOULOS GS, BARTELS SJ et al. Consensus statement: the upcoming crisis in geriatric mental health: challenges opportunities. Arch Gen Psychiatry 1999;56:848-853.
30. TSUANG MT, WOOLSON RF. Mortality in patients with schizophrenia, mania, depression and surgical conditions: a comparison with general population mortality. Br J Psychiatry 1997;130:162-166.
31. GAEBEL W, FROMMANN N. Long-term course in schizophrenia: concepts, methods and research strategies. Acta Psychiatr Scand 2000;102:49-53.
32. AUSLANDER LA, LINDAMER LL, DELAPENA J et al. A comparison of community-dwelling older schizophrenia patients by residential status. Acta Psychiatr Scand 2001;103:380-386.
33. HARVEY PD, HOWANITZ E, PARRELLA M et al. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. Am J Psychiatry 1998;155:1080-1086.
34. ARNOLD SE, GUR RE, SHAPIRO RM et al. Prospective clinico-pathologic studies of schizophrenia: accrual and assessment of patients. Am J Psychiatry 1995;152:731-737.
35. MCGLASHAN TH. Late onset improvement in chronic schizophrenia: characteristics and prediction. In: MILLER NE, COHEN GD, eds. Schizophrenia and aging. New York: Guilford Press, 1987:61-73.
36. HARVEY PD, LOMBARDI J, KINCAID MM et al. Cognitive functioning in chronically hospitalized schizophrenic patients: age-related changes and age disorientation as a predictor of impairment. Schizophr Res 1995;17:15-24.
37. ARRANZ B, BLENNOW K, EKMAN R, ERIKSSON A, MANSSON JE, MARCUSSON J. Brain monoaminergic and neuropeptidergic variations in human aging. J Neural Transm 1996;103:101-115.
38. CHECKOWAY H, NELSON LM. Epidemiologic approaches to the study of Parkinson's disease etiology. Epidemiology 1999;10:327-336.
39. GRANHOLM E, MORRIS S, ASARNOW RF, CHOCK D, JESTE DV. Accelerated age-related decline in processing resources in schizophrenia: evidence from pupillary responses recorded during the span of apprehension task. J Int Neuropsychol Soc 1999;6:30-43.
40. KAPLAN RM, ANDERSON JP. The general health policy model: an integrated approach. In: SPILKER B, ed. Quality of life assessments in clinical trials. New York: Raven, 1990;131-149.
41. CUFFEL BJ, JESTE DV, HALPAIN M, PRATT C, TARKE H, PATTERSON TL. Treatment costs and use of community mental health services for schizophrenia by age-cohorts. Am J Psychiatry 1996;153:870-876.
42. KRAEPLIN E. Über paranoide Erkrankungen. Zeitschrift für die gesamte Neurologie und Psychiatrie, Bd.11, 1912, S. 617-638.
43. DE LEON J, CANUSO C, WHITE AO SG. A pilot effort to determine benztropine equivalents of anticholinergic medications. Hosp Community Psychiatry 1994;45:606-607.
44. JESTE DV, WYATT RJ. Understanding and treating tardive dyskinesia. New York, NY: Guilford Press, Inc., 1982.